Trial Profile

A Randomized Double-Blind Controlled Study of CS-8958 Versus Oseltamivir Phosphate in Patients With Influenza Virus Infection

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Dec 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Laninamivir (Primary) ; Oseltamivir
Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza B virus infections
Focus Registrational; Therapeutic Use
Acronyms MARVEL
Sponsors Daiichi Sankyo Company

Most Recent Events

11 Oct 2010 Results published in Clinical Infectious Diseases.
10 Aug 2009 Top-line results reported in a Daiichi Sankyo Company media release.
10 Aug 2009 Data from this trial will be used in the NDA submission to the US FDA, according to a Daiichi Sankyo Company media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com